1. Introduction {#s0005}
===============

*Plantago major* L. (Plantaginaceae) belongs to the genus *Plantago*, which is represented by 21 species in Turkey and 2 of them are endemic ([@b0055]). Many species of *Plantago* genus have been documented as medicinal plants in numerous countries including Turkey for centuries ([@b0040], [@b0105], [@b0080]). *P. major* (common plantain) is the most known and widely used species in traditional medicine for treatment of wound, abscess, acnes, diabetes, and cancer ([@b0250], [@b0200], [@b0205], [@b0080], [@b0130]). Due to conspicuous veins on the leaves, *P. major* is named as "sinirli ot" in Turkey. There are three subspecies of *P. major*; *P. major* subsp*. major, P. major* subsp*. intermedia* and *P. major* subsp*. winteri* ([@b0010]). *P. major* subsp*. major* and *P. major* subsp*. intermedia* have been commonly used as a traditional medicine in Anatolia ([@b0040]). The presence of iridoid glucosides, phenylethanoid glycosides, flavonoids, terpenoids, phenolic acids and polysaccharides in *Plantago* species has been reported up to date ([@b0105], [@b0095], [@b0085], [@b0080], [@b0010]).

Though there has been an extensive investigation going on discovery of new collagenase, elastase and hyaluronidase enzyme inhibitory compounds of both synthetic and natural origins, a great essential still remains for new inhibitors of these enzymes owing to either side effects or low efficacy of present inhibitors. Further, the number of the current these enzyme inhibitors is quite limited, and new inhibitors are in demand mainly for cosmetics industry and wound healer. To date, we have investigated a large number of medicinal plants as well as natural compounds using several *in vivo* and *in vitro* experiments and as a result of these efforts we have find different collagenase, elastase, hyaluronidase enzyme inhibitors such as *Eucalyptus globulus* Labill., *Marsdenia erecta* R. Br., *Podospermum canum* C.A. Mey. etc. ([@b0225], [@b0005]). As part of our ongoing efforts on this road, in the current study we have aimed to investigate potential enzyme inhibitory activity of the aqueous extract and the isolated constituents (**1--3**) from the aerial parts of *Plantago major* subsp. *major* L.

2. Materials and methods {#s0010}
========================

2.1. Chemicals {#s0015}
--------------

Column chromatography was accomplished using polyamide (polyamide 6, 50--160 µm, Sigma-Aldrich, St. Louis, MO, USA), silica gel (Kieselgel 60, 70--230 mesh, Merck, Darmstadt, Germany), Sephadex LH-20 (GE Healthcare, Chicago, IL, USA) and LiChroprep C~18~ (40--63 µm, Merck). Thin layer chromatography (TLC) was carried out on pre-coated Kieselgel 60 F~254~, 0.2 mm aluminum plates (Merck). Chloroform (CHCl~3~), methanol (MeOH) and ethyl acetate (EtOAc) were obtained from Merck. Medium pressure liquid chromatography (MPLC) was performed on Buchi (3.5 × 45 cm) glass columns filled with LiChroprep C~18~ using Buchi Pump Module C-605 peristaltic pumps and Buchi Fraction Collector C-660 (Buchi AG, Flawil, Switzerland). NMR spectra were recorded for ^13^C NMR and ^1^H NMR by a Bruker AVANCE600 spectrometer (Billerrica, MA, USA) at 150 MHz and 600 MHz, respectively.

2.2. Plant material {#s0020}
-------------------

*P. major* subsp. *major* L. was collected from Maçka, Trabzon, Turkey, in June 2009. The voucher specimen, identified by Serdar Aslan (Department of Biology, Faculty of Sciences, Gazi University, Ankara, Turkey), has been deposited at the Herbarium of the Faculty of the Pharmacy, Hacettepe University, Ankara, Turkey \[HUEF 09009\].

2.3. Extraction, fractionation and purification procedure {#s0025}
---------------------------------------------------------

The air-dried and powdered aerial parts of the plant (65 g) were extracted with MeOH (3 × 500 mL) at 40 °C for 4 h. The combined extracts were concentrated under vacuum at 40 °C to obtain 15.4 g of crude MeOH extract. Crude extract was dissolved in distilled water and partitioned with petroleum ether to remove non-polar compounds. After removal of the petroleum ether phase, aqueous phase was evaporated and lyophilized to give 13.1 g of the aqueous extract.

11.0 g of the aqueous extract of aerial parts was chromatographed over a polyamide column to get five fractions (Fr. A: 0% MeOH; Fr. B: 25% MeOH; Fr. C: 50% MeOH; Fr. D: 75% MeOH; Fr. E: 100% MeOH) using increasing concentrations of methanol in H~2~O (0, 25, 50, 75 and 100%).

Fr. B (1 g) was subjected to MPLC using 0--100% MeOH as a solvent system to obtain compound **3**, **plantamajoside** (400 mg) with 35% MeOH.

Fr. C (164 mg), was applied to C-18 silica gel vacuum liquid chromatography (VLC) eluted with different concentrations of MeOH in H~2~O (0--100% MeOH) to get compound **2**, **homoplantaginin** (43.2 mg) with 40--45% MeOH.

Fr. D (250 mg), was also applied to C-18 silica gel vacuum liquid chromatography with increasing concentrations of MeOH in H~2~O (0--100% MeOH) and compound **1**, **calceorioside B** (34 mg) was yielded with 40% MeOH.

Structure elucidation of the isolated compounds was carried out by ^1^H-, ^13^C NMR, DEPT and 2D NMR (COSY, HSQC, HMBC) spectroscopy techniques.

2.4. Enzyme inhibitory activity studies {#s0030}
---------------------------------------

### 2.4.1. Hyaluronidase inhibitory activity assessment {#s0035}

The inhibition of hyaluronidase enzyme activity was evaluated by measuring the amount of *N*-acetylglucosamine released from sodium hyaluronate. 50 µL bovine hyaluronidase (7900 units/mL) dissolved in 0.1 M acetate buffer (pH 3.6) was mixed with 50 µL of different concentrations of the extracts dissolved in 5% DMSO. 50 µL of 5% DMSO was used instead of the extracts for the control group. After 20 min of incubation at 37 °C, 50 µL of calcium chloride (12.5 mM) was added to the mixture and again incubated for another 20 min in same conditions. 250 µL sodium hyaluronate (1.2 mg/mL) was added and incubated for 40 min in same way. After incubation, the mixture was treated with 50 µL of 0.4 M NaOH and 100 µL of 0.2 M sodium borate and then incubated for 3 min inside the boiling water bath. 1.5 mL of *p*-dimethylaminobenzaldehyde solution was added to the reaction mixture after cooling to room temperature and was further incubated at 37 °C for 20 min for color formation. The absorbance of this colored solution was measured at 585 nm (Beckmann Dual Spectrometer; Beckman, Fullerton, CA, USA) ([@b0135], [@b0190], [@b0225]).

### 2.4.2. Collagenase inhibitory activity assessment {#s0040}

The test samples were dissolved in DMSO. *Clostridium histolyticum* (ChC) was dissolved in 50 mM Tricine buffer (with 0.4 M NaCl and 0.01 M CaCl~2~, pH 7.5). 2 mM N-\[3-(2-Furyl)acryloyl\]-Leu-Gly-Pro-Ala (FALGPA) solution was prepared in the same buffer. 25 µL buffer, 25 µL test sample and 25 µL enzyme were added to each well and then incubated for 15 min. 50 µL substrate was added to the mixture to immediately measure the decrease of the optical density (OD) at 340 nm using a spectrometer.

The ChC inhibitory activity of each sample was calculated according to the following formula:$$\text{ChC\ inhibition\ activity}\;\left( \% \right) = \text{O}\text{D}_{\text{Control}} - - {\mspace{6mu}\text{O}}\text{D}_{\text{Sample}} \times 100/\text{O}\text{D}_{\text{Control}}$$where OD~control~ and OD~sample~ represent the optical densities in the absence and presence of sample, respectively ([@b0035], [@b0230]).

### 2.4.3. Elastase inhibitory activity assessment {#s0045}

Test sample solutions and human neutrophil elastase enzyme (HNE) (17 mU/mL) were mixed in 0.1 M Tris-HCl buffer (pH 7.5), then incubated at 25 °C for 5 min. *N*-Methoxysuccinyl-Ala-Ala-Pro-Val *p*-nitroanilide (MAAPVN) was added to the mixture and incubated at 37 °C for 1 h. Soybean trypsin inhibitor (1 mg/mL) was added to stop the reaction and the optical density due to the formation of *p*-nitroaniline was immediately measured at 405 nm. The HNE inhibitory activities were calculated as described in the ChC inhibitory activity ([@b0145], [@b0225]).

2.5. Statistical analysis of the data {#s0050}
-------------------------------------

The data obtained from *in vitro* enzyme inhibition assays were expressed as the standard deviation (S.D). One-way analysis of variance (ANOVA) was used to evaluate statistical differences between the reference and the test material groups. Dunnett's multiple comparison tests were used as post hoc tests. The values of *p* \< 0.05 was considered to be statistically significant \[\**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001, \*\*\*\**p* \< 0.0001\].

3. Results {#s0055}
==========

Our phytochemical studies on the aqueous extract prepared from the aerial parts of *P. major* subsp. *major* resulted in the isolation of three previously known compounds ([Fig. 1](#f0005){ref-type="fig"}). The chemical structures of these compounds were identified as calceorioside B (**1**), homoplantaginin (**2**) and plantamajoside (**3**) by comparing their spectroscopic data with the relevant literatures previously published ([@b0260], [@b0060], [@b0140], [@b0110]).Fig. 1Chemical structures of the isolated compounds 1--3.

Despite the extract (27.04%), and among the isolated compounds, calceorioside B (41.16%) exerted significant inhibition at 100 μg/mL when compared to reference compound, homoplantaginin and plantamajoside were found to be inactive in the hyaluronidase enzyme inhibition test at the same concentration ([Fig. 2](#f0010){ref-type="fig"}).Fig. 2Hyaluronidase inhibitory activity of the extracts and isolated compounds from *Plantago major* subsp. *major.*

Similar results were obtained from collagenase enzyme inhibition test. The extract (21.92%) and calceorioside B (28.34%) also caused notable inhibition in this test ([Fig. 3](#f0015){ref-type="fig"}). However, no remarkable inhibitory activity was observed for both the extract and the isolated compounds in the presence of the enzyme elastase ([Fig. 4](#f0020){ref-type="fig"}).Fig. 3Collagenase inhibitory activity of the extracts and isolated compounds from *Plantago major* subsp. *major.*Fig. 4Elastase inhibitory activity of the extracts and isolated compounds from *Plantago major* subsp. *major.*

4. Discussion {#s0060}
=============

The wound healing process comprises physiological events such as coagulation, formation of granulation tissue, reepithelization and remodeling of the extracellular matrix (ECM) ([@b0245]). Recent research has shown that the only function of the ECM is not to provide passive physical support for cells and that the ECM is also involved in tissue repair. Undistorted ECM molecules have been found to play an active role in the wound healing process with the ability to transform signals important for cellular processes in connection with growth factor activation ([@b0015]). The ECM molecules in the dermis consist of collagen, elastin, proteoglycans and glycosaminoglycans. Glycosaminoglycans interact with proteins and hyaluronic acid is the predominant glycosaminoglycan in the skin. Collagen, which is the most abundant protein in the ECM, plays a significant role in all phases of wound healing process. Elastin is another protein found in the ECM and gives elasticity to skin and other tissue ([@b0090]).

Nevertheless, inflammatory response accelerates the synthesis of dermal enzymes leading to degradation of ECM. Hyaluronic acid is depolymerized by hyaluronidase, elastase hydrolyzes fibrin and elastin fibers, and matrix metalloproteinases-1 particularly breaks the type I collagen. It has been suggested that the expression of dermal enzymes and the down-regulation of fiber synthesis play a major role in the process of skin wound ([@b0150]).

The injured tissues increase the formation of reactive oxygen products and reduce various enzymatic and non-enzymatic free radical scavengers and the presence of reactive oxygen radicals adversely affects the wound healing process ([@b0045]). In addition, excess of reactive oxygen species (ROS) causes inflammation, death of cells, tissue damage and reduction of the healing process, so antioxidant substances reduce the likelihood of these adverse events. Therefore, they seem important for the successful management of wounds ([@b0125]).

Calceorioside B **(1)**, is a phenylethanoid glycoside isolated from several medicinal plants which possess anticancer, antioxidant and neuroprotective potentials ([@b0025]). Harput et al. reported calceorioside A showed strong radical scavenging effects against DPPH, nitric oxide (NO) and superoxide (SO) anion radicals comparable to known antioxidants ([@b0095]). The matrix metalloproteinase enzymes have degenerative effects on the structural proteins but metalloproteinase inhibitors may reduce the severity of the injury and contribute the healing process. Thus, inhibition of hyaluronidase, collagenase and elastase enzymes, which break down these components, could be useful for the wound healing process. Indeed, it was previously reported that it is vital to minimize the level of these breakdown enzymes ([@b0070]). In the present study, calceorioside B was found to have both hyaluronidase and collagenase inhibitory activities which could clearly explain its wound healer potential.

Homoplantaginin (hispidulin-7-O-glucoside) **(2)** a flavonoid glucoside, is another phytochemical constituent markedly decreased the levels of tumor necrosis factor-*α* (TNF-*α*) and interleukin-1 (IL-1) in Bacillus Calmette--Guérin/lipopolysaccharide-induced hepatic injury model of mice ([@b0170]). Wu et al. reported that homoplantaginin ameliorates endothelial insulin resistance by inhibiting inflammation and modulating cell signalling via the IKKβ/IRS-1/pAkt/peNOS pathway ([@b0240]). Akram et al. demonstrated that homoplantaginin inhibited NO and PGE~2~ production, and iNOS and COX-2 protein expression through heme oxygenase-1 (HO-1) induction via activation of nuclear factor erythroid 2--related factor2 (Nrf2) ([@b0020]). In another study, palmitic acid-induced inflammation was inhibited by homoplantaginin through interacting with reactive oxygen species (ROS) sensitive thioredoxin protein. Protein and mRNA levels of inflammatory mediators (interleukin-1 beta, intercellular cell adhesion molecule-1, and monocyte chemotactic protein-1) were decreased by homoplantaginin. It has been indicated that homoplantaginin could protect endothelial cells from palmitic acid insult by restoring impaired NO generation ([@b0100]). Weng and Wang reported that homoplantaginin isolated from Salvia *plebeia* had also low antioxidant activity ([@b0235]). However, in the current study, homoplantaginin did not show inhibitory activity on all tested enzymes.

Previous bioactivity experiments carried out on plantamajoside **(3)**, another isolated phenylethanoid glycoside, revealed that this phytochemical has antioxidant ([@b0050]), antibiotic ([@b0210], [@b0175];; [@b0180], [@b0115], [@b0065]) and anti-inflammatory activities ([@b0155]) and has effect on nitrite formation, and iNOS expression induced by LPS ([@b0165]). Additionally, there are many studies showing that plantamajoside has inhibitory activity on cAMP phosphodiesterase ([@b0185], [@b0115], [@b0215], [@b0160], [@b0065]) and 5-lipoxygenase enzymes ([@b0185]) and also enzymatic lipid peroxidation ([@b0220]). However, in our study, no effect on hyaluronidase, collagenase or elastase enzyme was determined.

Of all the compounds tested, calceorioside B **(1)** has been considered the active compound of *P. major* subsp. *major* due to its inhibitory effect on collagenase and hyaluronidase in wound healing. Since excess of oxidative stress causes wound occurring, and wound healing process consists of different stages of inflammation; compounds with antioxidant and anti-inflammatory effects are also important for the treatment of wounds ([@b0195], [@b0030]). However, results obtained in this study are compatible with previous investigations on antioxidant and anti-inflammatory effects of some phenylethanoid glycosides ([@b0135], [@b0255], [@b0075]). In addition, the current study supports the wound healing usage of *Plantago* genus ([@b0265], [@b0120], [@b0270], [@b0080]). On the other hand, *in vitro* wound healing related enzyme activity of *P. major* subsp. *major* and isolated three compounds are reported for the first time in this study.

5. Conclusion {#s0065}
=============

Consequently, aqueous extract of aerial parts of *P. major* subsp. *major* and only calceorioside B among three compounds isolated from the plant have been revealed to exert a prominent collagenase and hyaluronidase enzyme inhibitory activity. The highest inhibitory effect of calceorioside B compared to the extract showed the lack of synergistic effect between the extract and tested compounds. In this study, we disclose the first *in vitro* study on hyaluronidase and collagenase inhibitory effects of calceorioside B, which might be a promising precursor model for enzyme-inhibiting molecules with wound healer potential.
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